PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Trulieve Cannabis Corp.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Trulieve Cannabis Corp.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Debt Due Cover Ratio: Debt due within a year is covered 66.9 times by its yearly operating cash. Higher than 96% of Healthcare companies in United States.

Where $100 of sales goes

$87Operating costs$5.4Interest$9.9Net loss

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

2.9×

Over the last 3 years its own operating cash covered its investment spending (capex) 2.9 times.

Higher than 79% of Healthcare companies in United States.

Cash Locked Ratio

$18

For every $100 of sales, $18 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $17 tied up three years earlier.

Less money tied up than 62% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

1/3 · 2/3

Sales grew in 1 of the last 3 years; profit grew in 2 of 3.

Steadier than 50% of Healthcare companies in United States.

Growth Efficiency Ratio

—

Sales barely changed

Sales changed by -3% in 3 years, too little to measure extra profit per extra sales.

Asset Productivity Ratio

-3% / -21%

In 3 years sales changed by -3% while total assets changed by -21%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

66.9×

Debt due within a year is covered 66.9 times by its yearly operating cash.

Higher than 96% of Healthcare companies in United States.

Cash Cushion Ratio

−15%

Debt, after subtracting cash, equals 15% of its market value (net debt).

Lower than 82% of Healthcare companies in United States.

Tangible Assets Ratio

52%

Of every $100 the company owns, $52 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 77% of Healthcare companies in United States.

Tangible Net Worth Ratio

Negative

Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.

Less tangible than 76% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+3%

Share count rose 3% in 3 years, so each share's slice of the company became smaller.

Smaller rise in share count than 77% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Trulieve Cannabis Corp. made a loss over the last year. Trulieve Cannabis Corp. owes $0.63 for every $1 it owns. Trulieve Cannabis Corp. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Trulieve Cannabis Corp. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

2.74

The share price is 2.74 times Trulieve Cannabis Corp.'s book value per share, higher than 53% of Healthcare companies in United States.

Market cap

$2.1 B

The total market value of all of Trulieve Cannabis Corp.'s shares at today's price (share price × number of shares), larger than 76% of Healthcare companies in United States. PosiCap size class: Meso Cap.

Net worth (book value)

$767 M

What Trulieve Cannabis Corp. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$3.99

Net worth divided by the number of shares. The share price of $10.92 is 2.7 times this, which is the P/B above.

Return on equity (ROE)

-47.7%

Trulieve Cannabis Corp. lost 47.7% of its shareholders' money over the last year, higher than 50% of Healthcare companies in United States.

Owes vs Owns

0.63×

Trulieve Cannabis Corp. owes $0.63 for every $1 it owns (moderate), higher than 66% of Healthcare companies in United States.

Dividend yield

None

Trulieve Cannabis Corp. does not currently pay a dividend.

Revenue growth

-0%

Revenue fell 0% in the year to Dec 2025, and shrank 1% a year on average over 3 years.

Profit growth

Loss

Trulieve Cannabis Corp. made a loss in each of the last two years.

Profit margin

-9.9%

Trulieve Cannabis Corp. lost $10 for every $100 of revenue.

Interest cover

2.3×

Trulieve Cannabis Corp.'s operating profit covered its interest costs 2.3 times in the year to Dec 2025.

Cash vs debt

Net debt

Trulieve Cannabis Corp. had $308 M more debt than cash (net debt) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Trulieve Cannabis Corp.: $2.1 B ÷ $767 M (30 Jun 2026) = 2.7.

What is Trulieve Cannabis Corp.'s return on equity?

Trulieve Cannabis Corp. lost 47.7% of its shareholders' money over the last year, higher than 50% of Healthcare companies in United States.

How much does Trulieve Cannabis Corp. owe compared with what it owns?

Trulieve Cannabis Corp. owes $0.63 for every $1 it owns (moderate), higher than 66% of Healthcare companies in United States.

Does Trulieve Cannabis Corp. pay a dividend?

No. Trulieve Cannabis Corp. does not currently pay a dividend.

Is Trulieve Cannabis Corp.'s revenue growing?

Revenue fell 0% in the year to Dec 2025, and shrank 1% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.